Sandbox/00008: Difference between revisions
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
<div style="width: 1px; height: 1px; background-color: #999999; position: fixed; top: 10px; left: 10px"></div> | |||
<div style="width: 90%; -webkit-user-select: none;"> | |||
==FIRE: Focused Initial Rapid Evaluation== | ==FIRE: Focused Initial Rapid Evaluation== | ||
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. | A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.<ref name="Robin-2006">{{Cite journal | last1 = Robin | first1 = E. | last2 = Costecalde | first2 = M. | last3 = Lebuffe | first3 = G. | last4 = Vallet | first4 = B. | title = Clinical relevance of data from the pulmonary artery catheter. | journal = Crit Care | volume = 10 Suppl 3 | issue = | pages = S3 | month = | year = 2006 | doi = 10.1186/cc4830 | PMID = 17164015 }}</ref> | ||
<span style="font-size:85%">Boxes in the salmon color signify that an urgent management is needed.</span> | <span style="font-size:85%">Boxes in the salmon color signify that an urgent management is needed.</span> | ||
Line 22: | Line 26: | ||
SaO2, arterial oxygen saturation; | SaO2, arterial oxygen saturation; | ||
SBP, systolic blood pressure; | SBP, systolic blood pressure; | ||
ScvO2, central venous oxygen saturation; | |||
SMA-7, sequential multiple analysis-7. | SMA-7, sequential multiple analysis-7. | ||
</span> | </span> | ||
Line 31: | Line 35: | ||
❑ Evidence of hypoperfusion | ❑ Evidence of hypoperfusion | ||
: ❑ [[Altered mental status|<span style="color: #000000;">Altered mental status</span>]] | : ❑ [[Altered mental status|<span style="color: #000000;">Altered mental status</span>]] | ||
: ❑ [[ | : ❑ [[Cold extremities|<span style="color: #000000;">Cold extremities</span>]] | ||
: ❑ [[Cyanosis|<span style="color: #000000;">Cyanosis</span>]] | : ❑ [[Cyanosis|<span style="color: #000000;">Cyanosis</span>]] | ||
: ❑ [[Oliguria|<span style="color: #000000;">Oliguria</span>]] | : ❑ [[Oliguria|<span style="color: #000000;">Oliguria</span>]] | ||
Line 45: | Line 49: | ||
|A05=<div style="text-align: center; background: #FA8072; color: #FFFFFF; padding: 15px; font-weight: bold;"><BIG>'''Proceed to <br> [[shock resident survival guide|<span style="color: #FFFFFF;">shock resident survival guide</span>]] <br> to identify and correct the cause'''</BIG></div>}} | |A05=<div style="text-align: center; background: #FA8072; color: #FFFFFF; padding: 15px; font-weight: bold;"><BIG>'''Proceed to <br> [[shock resident survival guide|<span style="color: #FFFFFF;">shock resident survival guide</span>]] <br> to identify and correct the cause'''</BIG></div>}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A06 | | | | | | | | |A06=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate management'''</BIG> | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A06 | | | | | | | | |A06=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''[[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;">Immediate management ''(click for details)''</span>]]'''</BIG> | ||
❑ [[Intubation|<span style="color: #FFFFFF;">Intubation</span>]] with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]] | ❑ [[Intubation|<span style="color: #FFFFFF;">Intubation</span>]] with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]] | ||
❑ ± | ❑ ± [[Norepinephrine|<span style="color: #FFFFFF;">Norepinephrine</span>]] IV infusion 0.1–2.0 μg/kg/min</div>}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A07 | | | | | | | | |A07=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Workup'''</BIG> | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A07 | | | | | | | | |A07=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate Workup'''</BIG> | ||
❑ [[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]] | ❑ [[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]] | ||
Line 85: | Line 80: | ||
❑ [[ICU|<span style="color: #FFFFFF;">ICU admission</span>]] | ❑ [[ICU|<span style="color: #FFFFFF;">ICU admission</span>]] | ||
❑ [[Cardiology|<span style="color: #FFFFFF;">Cardiology consultation</span>]] | |||
❑ Hold [[antihypertensive|<span style="color: #FFFFFF;">antihypertensive medications</span>]] | |||
</div>}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A08 | | | | | | | | |A08=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: preload'''</BIG> | |||
❑ '''Goal: [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] 14–18 mm Hg''' | |||
: ❑ ↑ [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] by [[Normal saline|<span style="color: #FFFFFF;">normal saline</span>]] IV bolus 100–200 mL | |||
: ❑ ↓ [[PCWP|<span style="color: #FFFFFF;">PCWP</span>]] by [[Furosemide|<span style="color: #FFFFFF;">furosemide</span>]] slow IV injection (over 1–2 min) | |||
: ❑ ± Correct [[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;"> pulmonary congestion '''''(click for details)'''''</span>]] | |||
: ❑ ± [[Morphine|<span style="color: #FFFFFF;">Morphine</span>]] 2–4 mg slow IV injection (over 1–5 min) | |||
</div>}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A09 | | | | | | | | |A09=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: afterload'''</BIG> | |||
❑ '''Goal: [[MAP|<span style="color: #FFFFFF;">MAP</span>]] >60 mm Hg, [[SVR|<span style="color: #FFFFFF;">SVR</span>]] 800–1200 dyn·s·cm<sup>−5</sup>''' | |||
: ❑ If ↑ MAP & ↑ SVR: wean [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] ± [[vasodilator|<span style="color: #FFFFFF;">vasodilators</span>]] | |||
: ❑ If ↓ MAP & ↑ SVR: [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] + [[inotrope|<span style="color: #FFFFFF;">inotropes</span>]] | |||
: ❑ If ↓ MAP & ↓ SVR: [[vasopressor|<span style="color: #FFFFFF;">vasopressors</span>]] ± [[vasopressin|<span style="color: #FFFFFF;">vasopressin</span>]] | |||
</div>}} | </div>}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A10 | | | | | | | | |A10=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Hemodynamic optimization: cardiac index'''</BIG> | ||
❑ [[ | ❑ '''Goal: [[CI|<span style="color: #FFFFFF;">CI</span>]] >2.2 L/min/m<sup>2</sup>''' | ||
❑ [[ | : ❑ ± [[Dobutamine|<span style="color: #FFFFFF;">Dobutamine</span>]] | ||
❑ [[ | : ❑ ± [[Milrinone|<span style="color: #FFFFFF;">Milrinone</span>]] | ||
: ❑ ± [[IABP|<span style="color: #FFFFFF;">IABP</span>]], [[VAD|<span style="color: #FFFFFF;">VAD</span>]], or [[ECMO|<span style="color: #FFFFFF;">ECMO</span>]] if refractory</div>}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A11 | | | | | | | | |A11=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate goals'''</BIG> | |||
❑ [[ | ❑ [[SaO2|<span style="color: #FFFFFF;">SaO2</span>]] >90%–92% | ||
❑ [[ | ❑ [[CVP|<span style="color: #FFFFFF;">CVP</span>]] 8–12 mm Hg | ||
❑ [[mixed venous oxygen saturation|<span style="color: #FFFFFF;">MVO2 | ❑ [[mixed venous oxygen saturation|<span style="color: #FFFFFF;">MVO2</span>]] >60% | ||
❑ [[SCVO2|<span style="color: #FFFFFF;"> | ❑ [[SCVO2|<span style="color: #FFFFFF;">ScvO2</span>]] >70% | ||
❑ [[Hemoglobin|<span style="color: #FFFFFF;">Hemoglobin >7–9 g/dL | ❑ [[Hemoglobin|<span style="color: #FFFFFF;">Hemoglobin</span>]] >7–9 g/dL | ||
❑ [[Lactate|<span style="color: #FFFFFF;">Lactate <2.2 mM/L | ❑ [[Lactate|<span style="color: #FFFFFF;">Lactate</span>]] <2.2 mM/L | ||
❑ [[urine output|<span style="color: #FFFFFF;">Urine output >0.5 mL/kg/h | ❑ [[urine output|<span style="color: #FFFFFF;">Urine output</span>]] >0.5 mL/kg/h | ||
❑ ± Correct [[arrhythmia|<span style="color: #FFFFFF;">arrhythmia</span>]] | ❑ ± Correct [[arrhythmia|<span style="color: #FFFFFF;">arrhythmia</span>]] | ||
Line 113: | Line 141: | ||
❑ ± Correct [[electrolyte disturbance|<span style="color: #FFFFFF;">electrolyte disturbance</span>]]</div>}} | ❑ ± Correct [[electrolyte disturbance|<span style="color: #FFFFFF;">electrolyte disturbance</span>]]</div>}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | ||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| | {{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A12 |-| A13 | | | | | |A12=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''[[{{PAGENAME}}#Immediate management|<span style="color: #FFFFFF;">ACS likely? ''(click for details)''</span>]]'''</BIG> | ||
❑ [[cardiac biomarkers|<span style="color: #FFFFFF;">Positive cardiac biomarkers (cTnT, cTnI, or CK-MB)</span>]] | |||
❑ Symptoms of myocaridal ischemia | |||
❑ New significant ECG findings of myocardial ischemia | |||
</div> | |||
|A13=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 16px;"><BIG><BIG>'''YES, then manage as <br> UA/STEMI <br> and proceed to <br> [[{{PAGENAME}}#Acute Ischemia Pathway|<span style="color: #FFFFFF;">acute ischemia pathway</span>]]'''</BIG></BIG> | |||
</div>}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}} | |||
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A14 | | | | | | | | |A14=<div style="text-align: center; background: #FA8072; color: #FFFFFF; font-weight: bold; padding: 15px;"><BIG>No, then proceed to <br> [[{{PAGENAME}}#Complete Diagnostic Approach|<span style="color: #FFFFFF;">complete diagnostic approach</span>]]</BIG></div>}} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
==Acute Ischemia Pathway== | |||
<!--return to top--> | |||
==References== | |||
{{reflist|2}} | |||
[[Category:Disease]] | |||
[[Category:Pulmonology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Medicine]] | |||
[[Category:Resident survival guide]] |
Revision as of 05:40, 21 April 2014
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1]
Boxes in the salmon color signify that an urgent management is needed.
Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; MVO2, mixed venous oxygen saturation; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; ScvO2, central venous oxygen saturation; SMA-7, sequential multiple analysis-7.
Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?
❑ Evidence of hypoperfusion
| |||||||||||||||||||||||
YES | NO | ||||||||||||||||||||||
Cardiogenic shock suspected | |||||||||||||||||||||||
Immediate management (click for details)
❑ Intubation with mechanical ventilation ❑ ± Norepinephrine IV infusion 0.1–2.0 μg/kg/min | |||||||||||||||||||||||
Immediate Workup
❑ Lactate ❑ Hold antihypertensive medications | |||||||||||||||||||||||
Hemodynamic optimization: preload
❑ Goal: PCWP 14–18 mm Hg
| |||||||||||||||||||||||
Hemodynamic optimization: afterload
❑ Goal: MAP >60 mm Hg, SVR 800–1200 dyn·s·cm−5
| |||||||||||||||||||||||
Immediate goals
❑ SaO2 >90%–92% ❑ CVP 8–12 mm Hg ❑ MVO2 >60% ❑ ScvO2 >70% ❑ Hemoglobin >7–9 g/dL ❑ Lactate <2.2 mM/L ❑ Urine output >0.5 mL/kg/h ❑ ± Correct arrhythmia ❑ ± Correct electrolyte disturbance | |||||||||||||||||||||||
ACS likely? (click for details)
❑ Positive cardiac biomarkers (cTnT, cTnI, or CK-MB) ❑ Symptoms of myocaridal ischemia ❑ New significant ECG findings of myocardial ischemia | |||||||||||||||||||||||
No, then proceed to complete diagnostic approach | |||||||||||||||||||||||
Acute Ischemia Pathway
References
- ↑ Robin, E.; Costecalde, M.; Lebuffe, G.; Vallet, B. (2006). "Clinical relevance of data from the pulmonary artery catheter". Crit Care. 10 Suppl 3: S3. doi:10.1186/cc4830. PMID 17164015.